Van Dooren Pascal 4

Accession 0000899243-19-004233

CIK 0001348036other

View on SEC.gov Company Profile

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 4:17 PM ET

Size

34.0 KB

Accession

0000899243-19-004233

Insider Transaction Report

Form 4

Period: 2019-02-15

AVALARA, INC.AVLR

Van Dooren Pascal

See Remarks

Transactions

Exercise/Conversion
Common Stock
2019-02-15$4.50/sh+25,000$112,500→ 81,290 total
Exercise/Conversion
Common Stock
2019-02-15$1.90/sh+27,314$51,897→ 56,290 total
Exercise/Conversion
Common Stock
2019-02-15$4.50/sh+25,000$112,500→ 106,290 total
Exercise/Conversion
Common Stock
2019-02-15$8.04/sh+175,000$1,407,000→ 384,893 total
Exercise/Conversion
Common Stock
2019-02-15$12.34/sh+32,652$402,926→ 162,900 total
Exercise/Conversion
Common Stock
2019-02-15$13.84/sh+46,993$650,383→ 209,893 total
Exercise/Conversion
Stock Option (Right to Buy)
2019-02-15−27,314→ 0 total
Exercise: $1.90From: 2015-10-03Exp: 2021-12-13→ Common Stock (27,314 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2019-02-15−25,000→ 0 total
Exercise: $4.50From: 2017-01-01Exp: 2023-02-13→ Common Stock (25,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2019-02-15−23,958→ 1,042 total
Exercise: $12.20From: 2019-01-01Exp: 2025-01-28→ Common Stock (23,958 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2019-02-15−46,993→ 55,539 total
Exercise: $13.84Exp: 2027-02-09→ Common Stock (46,993 underlying)
Exercise/Conversion
Common Stock
2019-02-15$12.20/sh+23,958$292,288→ 130,248 total
Sale
Common Stock
2019-02-15$49.29/sh−138,127$6,808,280→ 246,766 total
Sale
Common Stock
2019-02-15$49.75/sh−217,790$10,835,053→ 28,976 total
Exercise/Conversion
Stock Option (Right to Buy)
2019-02-15−25,000→ 25,000 total
Exercise: $4.50From: 2017-01-01Exp: 2023-02-13→ Common Stock (25,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2019-02-15−175,000→ 0 total
Exercise: $8.04From: 2018-01-01Exp: 2024-02-25→ Common Stock (175,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2019-02-15−32,652→ 19,592 total
Exercise: $12.34Exp: 2026-06-16→ Common Stock (32,652 underlying)

Footnotes (6)

[F1]Includes 1,463 shares purchased under the Avalara, Inc. 2018 Employee Stock Purchase Plan on January 31, 2019.
[F2]The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 28, 2018.
[F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.95 to $49.525, inclusive. Upon request by Avalara, Inc., any security holder thereof, or the staff of the Securities and Exchange Commission, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range.
[F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.53 to $50.14, inclusive. Upon request by Avalara, Inc., any security holder thereof, or the staff of the Securities and Exchange Commission, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range.
[F5]The option grant was for 52,244 shares of common stock with the following vesting schedule: 25% of the shares vested on May 5, 2017, and 1/48 vest monthly thereafter, such that the option will be fully vested on May 5, 2020.
[F6]The option grant was for 102,532 shares of common stock with the following vesting schedule: 25% of the shares vested on January 1, 2018, and 1/48 vest monthly thereafter, such that the option will be fully vested on January 1, 2021.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

AVALARA, INC.

CIK 0001348036

→

Entity typeother

Related Parties

filerCIK 0001741465

Filing Metadata

Form type: 4
Filed: Feb 19, 7:00 PM ET
Accepted: Feb 20, 4:17 PM ET
Size: 34.0 KB

View on SEC.gov